Genus

Website: Genus
Index: FTSE 250
EPIC: GNS
Supersector: Health Care
Sector: Pharmaceuticals and Biotechnology
Subsector: Biotechnology
Market Cap: £1.75B
Payout Frequency: Semi-Annual

Genus Dividend Analysis and Summary

Key Dividend Details
  • Dividend type: Interim
  • Dividend per share: 11.2p (up +9% vs 10.3p prior interim)
  • Record date: 06/03/2026
  • Ex-dividend date: 05/03/2026 (derived as one business day before the record date)
  • Payment date: 27/03/2026
  • Policy framework: Board updated policy to a 30–40% payout of adjusted EPS for the full year; interim set at 35% of the prior full-year dividend (32.0p in FY25 ? 11.2p interim)
  • Earnings cover: Rolling 12-month adjusted earnings cover of the dividend at 3.1x (FY25 full-year cover was 2.6x)
Sustainability and Growth Outlook
  • Earnings support: H1 adjusted EPS rose to 60.8p (+53%), with adjusted PBT up 57%. This underpins the higher interim.
  • Cash and balance sheet: H1 free cash inflow of £8.2m; net debt/adjusted EBITDA improved to 1.4x (ample covenant headroom, facilities to 2029). Cash conversion dipped to 60% due to working capital outflows.
  • Near-term cash catalyst: Expected JV proceeds of ~£100m in fiscal Q4 (formation of Chinese porcine JV) should further strengthen liquidity and reduce leverage, supporting dividend capacity.
  • Policy clarity: The 30–40% adjusted EPS payout range and formulaic interim (35% of prior full-year dividend) provide visibility and smoothing. Given rolling 12-month adjusted EPS and improving cover, the progressive trajectory looks maintainable absent a sharp earnings or cash downturn.
Read more

Genus Annual Dividend Yield - 1.2%

Dividends Used in Calculation:

Ex-Dividend Date Payment Date Type Amount Currency
06/03/2025 04/04/2025 Interim 10.30p GBX
06/11/2025 05/12/2025 Final 21.70p GBX

Total (Annual Dividends Per Share): 32.00p

Dividend Yield = Annual Dividends Per Share (32.00p) ÷ Share Price (2675p) = 1.2%

Genus Dividend History

Ex Dividend Date Payment Date Type Amount Currency
05/03/2026 27/03/2026 Interim 11.2000p GBX
06/11/2025 05/12/2025 Final 21.70p GBX
06/03/2025 04/04/2025 Interim 10.30p GBX
07/11/2024 06/12/2024 Final 21.70p GBX
29/02/2024 28/03/2024 Interim 10.30p GBX
09/11/2023 08/12/2023 Final 21.70p GBX
02/03/2023 30/03/2023 Interim 10.30p GBX
17/11/2022 09/12/2022 Final 21.70p GBX
03/03/2022 31/03/2022 Interim 10.30p GBX
18/11/2021 10/12/2021 Final 21.70p GBX
04/03/2021 01/04/2021 Interim 10.30p GBX
19/11/2020 11/12/2020 Final 19.70p GBX
05/03/2020 02/04/2020 Interim 9.40p GBX
07/11/2019 29/11/2019 Final 18.80p GBX
07/03/2019 04/04/2019 Interim 8.90p GBX
15/11/2018 30/11/2018 Final 17.90p GBX
08/03/2018 04/04/2018 Interim 8.10p GBX
16/11/2017 01/12/2017 Final 16.20p GBX
02/03/2017 31/03/2017 Interim 7.40p GBX
17/11/2016 02/12/2016 Final 14.70p GBX
03/03/2016 30/03/2016 Interim 6.70p GBX
19/11/2015 04/12/2015 Final 13.40p GBX
05/03/2015 27/03/2015 Interim 6.10p GBX
20/11/2014 05/12/2014 Final 12.20p GBX
05/03/2014 28/03/2014 Interim 5.50p GBX
16/11/2013 06/12/2013 Final 11.10p GBX
13/03/2013 08/04/2013 Interim 5.00p GBX
Year Interim Final Currency Total Change
2024 10.300 21.700 GBX 32.000 0.000
2023 10.300 21.700 GBX 32.000 0.000
2022 10.300 21.700 GBX 32.000 0.000
2021 10.300 21.700 GBX 32.000 9.960
2020 9.400 19.700 GBX 29.100 5.050
2019 8.900 18.800 GBX 27.700 6.530
2018 8.100 17.900 GBX 26.000 10.160
2017 7.400 16.200 GBX 23.600 10.280
2016 6.700 14.700 GBX 21.400 9.740
2015 6.100 13.400 GBX 19.500 10.160
2014 5.500 12.200 GBX 17.700 9.930
2013 5.000 11.100 GBX 16.100

Genus Dividend Calculator

PaymentPaidAmount
Next
Previous

Genus Dividend Growth

Dividend Growth (1Y) 2.81%
Dividend CAGR (5Y) 1.86%
Years of Growth
Payout Ratio 44.42%
Buyback Yield -2.04%
Shareholder Yield -0.84%
P/E Ratio (TTM)37.2
Forward P/E25.28
P/FCF34.64
Earnings Yield2.69%
FCF Yield2.89%
ROE9.35%
ROCE10.5%
Profit Margin7.07%
Operating Margin12.29%
Gross Margin40.12%